紫光學大(000526.SZ):天津安特累計增持199.57萬股
格隆匯2月12日丨紫光學大(000526.SZ)公佈,公司收到天津安特文化傳播有限公司(“天津安特”)及其一致行動人浙江台州椰林灣投資策劃有限公司(“椰林灣”)編制的《詳式權益變動報告書》、《關於權益變動事項的告知函》,天津安特在2019年12月18日至2020年2月11日期間,通過深圳證券交易所的證券交易累計增持公司約199.57萬股無限售流通股股份,佔公司總股本的2.07%。
此次權益變動完成後,天津安特將直接持有紫光學大680.05萬股股份,通過椰林灣間接持有紫光學大1243.85萬股股份,合計持有紫光學大1923.91萬股股份,佔紫光學大總股本的20.00%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.